Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide

Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide

Background: Glioblastoma (GBM) is a very poor-prognosis brain tumor. To date, maximal excision followed by radiochemotherapy, in 30 fractions, is the standard approach. Limited data are present in the literature about hypofractionated radiotherapy (hypo-RT) in GBM poor prognosis patients. Thus, this...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fabiana Gregucci, Alessia Surgo, Ilaria Bonaparte, Letizia Laera, Maria Paola Ciliberti, Roberta Carbonara, Maria Annunziata Gentile, David Giraldi, Roberto Calbi, Morena Caliandro, Nicola Sasso, Salvatore D’Oria, Carlo Somma, Gaetano Martinelli, Giammarco Surico, Giuseppe Lombardi, Alba Fiorentino
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
glioblastoma
poor prognosis
radiotherapy
chemotherapy
Medicine
R
Acceso en línea:https://doaj.org/article/af3579c3dc55499992afbba282d6db59
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/af3579c3dc55499992afbba282d6db59

Ejemplares similares